NO940736L - DNA sekvenser som koder for gelonin polypeptid - Google Patents

DNA sekvenser som koder for gelonin polypeptid

Info

Publication number
NO940736L
NO940736L NO940736A NO940736A NO940736L NO 940736 L NO940736 L NO 940736L NO 940736 A NO940736 A NO 940736A NO 940736 A NO940736 A NO 940736A NO 940736 L NO940736 L NO 940736L
Authority
NO
Norway
Prior art keywords
dna sequences
gelonin
sequences encoding
synthetic gene
encoding gelonin
Prior art date
Application number
NO940736A
Other languages
English (en)
Other versions
NO317659B1 (no
NO940736D0 (no
Inventor
Michael G Rosenblum
Kenneth L Beattie
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of NO940736L publication Critical patent/NO940736L/no
Publication of NO940736D0 publication Critical patent/NO940736D0/no
Publication of NO317659B1 publication Critical patent/NO317659B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A61K47/6819—Plant toxins
    • A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
NO19940736A 1991-09-06 1994-03-03 Syntetisk DNA som koder for gelonin-polypeptid, fremgangsmate for fremstilling av dette, samt en vertscelle som inneholder en ekspresjonsvektor omfattende nevnte syntetiske DNA NO317659B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75594991A 1991-09-06 1991-09-06
PCT/US1992/007066 WO1993005168A1 (en) 1991-09-06 1992-08-21 Dna sequences encoding gelonin polypeptide

Publications (3)

Publication Number Publication Date
NO940736L true NO940736L (no) 1994-03-03
NO940736D0 NO940736D0 (no) 1994-03-03
NO317659B1 NO317659B1 (no) 2004-11-29

Family

ID=25041367

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19940736A NO317659B1 (no) 1991-09-06 1994-03-03 Syntetisk DNA som koder for gelonin-polypeptid, fremgangsmate for fremstilling av dette, samt en vertscelle som inneholder en ekspresjonsvektor omfattende nevnte syntetiske DNA

Country Status (18)

Country Link
US (1) US5624827A (no)
EP (1) EP0602144B1 (no)
JP (1) JPH06510431A (no)
KR (1) KR100270195B1 (no)
CN (1) CN1047402C (no)
AT (1) ATE173023T1 (no)
AU (1) AU679427B2 (no)
CA (1) CA2115049C (no)
DE (1) DE69227519T2 (no)
DK (1) DK0602144T3 (no)
ES (1) ES2123008T3 (no)
FI (1) FI113547B (no)
IL (1) IL103057A (no)
NO (1) NO317659B1 (no)
NZ (1) NZ244220A (no)
RU (1) RU2142015C1 (no)
WO (1) WO1993005168A1 (no)
ZA (1) ZA926705B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5317009A (en) * 1991-08-26 1994-05-31 New York University Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof
US5621083A (en) * 1991-11-04 1997-04-15 Xoma Corporation Immunotoxins comprising ribosome-inactivating proteins
US6146850A (en) * 1991-11-04 2000-11-14 Xoma Corporation Proteins encoding gelonin sequences
US5837491A (en) * 1991-11-04 1998-11-17 Xoma Corporation Polynucleotides encoding gelonin sequences
WO1993011794A1 (en) * 1991-12-13 1993-06-24 Xoma Corporation Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
US5869619A (en) * 1991-12-13 1999-02-09 Xoma Corporation Modified antibody variable domains
AU6912294A (en) * 1993-05-12 1994-12-12 Xoma Corporation Immunotoxins comprising ribosome-inactivating proteins
US20030166169A1 (en) * 1998-01-16 2003-09-04 Padgett Hal S. Method for constructing viral nucleic acids in a cell-free manner
ZA200305980B (en) * 2001-02-12 2007-01-31 Res Dev Foundation Modified proteins, designer toxins, and methods of making thereof
CA2454048C (en) * 2001-07-17 2011-05-03 Research Development Foundation Therapeutic agents comprising pro-apoptotic proteins
JP2006506964A (ja) * 2002-06-12 2006-03-02 リサーチ ディベロップメント ファンデーション 治療剤としての免疫毒素及びその利用
DK1551876T3 (da) 2002-10-16 2011-06-14 Purdue Pharma Lp Antistoffer, der binder til celle-associerede ca 125/0722P og fremgangsmåder til anvendelse deraf
JP2008528633A (ja) * 2005-02-01 2008-07-31 リサーチ ディベロップメント ファウンデーション Blysレセプターを標的化するためのblys融合タンパク質およびb細胞増殖性疾患の処置方法
US8759036B2 (en) * 2011-03-21 2014-06-24 Affymetrix, Inc. Methods for synthesizing pools of probes
LT2768607T (lt) 2011-09-26 2021-12-27 Thermo Fisher Scientific Geneart Gmbh Daugiašulininė plokštelė didelio efektyvumo, mažo tūrio nukleorūgščių sintezei atlikti
US12595500B2 (en) 2011-09-26 2026-04-07 Life Technologies Corporation High efficiency, small volume nucleic acid synthesis
WO2014153188A2 (en) 2013-03-14 2014-09-25 Life Technologies Corporation High efficiency, small volume nucleic acid synthesis
EP3456734B1 (en) 2012-10-04 2022-01-05 Research Development Foundation Serine protease molecules and therapies
WO2016094512A1 (en) 2014-12-09 2016-06-16 yLIFE TECHNOLOGIES CORPORATION High efficiency, small volume nucleic acid synthesis
EP3763818A1 (en) 2015-10-06 2021-01-13 Pierce Biotechnology, Inc. Devices and methods for producing proteins
US20210147830A1 (en) 2018-06-29 2021-05-20 Thermo Fisher Scientific Geneart Gmbh High throughput assembly of nucleic acid molecules
GB201905303D0 (en) 2019-04-15 2019-05-29 Thermo Fisher Scient Geneart Gmbh Multiplex assembly of nucleic acid molecules
EP4114972A1 (en) 2020-03-06 2023-01-11 Life Technologies Corporation High sequence fidelity nucleic acid synthesis and assembly
WO2024132094A1 (en) 2022-12-19 2024-06-27 Thermo Fisher Scientific Geneart Gmbh Retrieval of sequence-verified nucleic acid molecules
GB2628173A (en) 2023-03-17 2024-09-18 Thermo Fisher Scient Geneart Gmbh Methods of producing modified nucleic acid sequences for eliminating adverse splicing events

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888415A (en) * 1985-03-04 1989-12-19 Dana-Farber Cancer Institute, Inc. Gelonin immunotoxin
US5024947A (en) * 1987-07-24 1991-06-18 Cetus Corporation Serum free media for the growth on insect cells and expression of products thereby
US5290914A (en) * 1988-04-28 1994-03-01 Mycogen Corporation Hybrid diphtheria-B.t. pesticidal toxins
IE912716A1 (en) * 1990-08-14 1992-02-26 Res Dev Foundation Protein Structure of the Plant Toxin Gelonin

Also Published As

Publication number Publication date
DE69227519T2 (de) 1999-06-02
JPH06510431A (ja) 1994-11-24
IL103057A0 (en) 1993-02-21
IL103057A (en) 1999-09-22
US5624827A (en) 1997-04-29
RU2142015C1 (ru) 1999-11-27
CA2115049C (en) 2003-10-21
NZ244220A (en) 1994-12-22
WO1993005168A1 (en) 1993-03-18
EP0602144B1 (en) 1998-11-04
RU94034733A (ru) 1996-06-10
NO317659B1 (no) 2004-11-29
EP0602144A4 (en) 1995-03-15
KR100270195B1 (ko) 2001-03-02
CN1047402C (zh) 1999-12-15
ZA926705B (en) 1993-04-28
DK0602144T3 (da) 1999-07-19
DE69227519D1 (de) 1998-12-10
FI113547B (fi) 2004-05-14
AU2547692A (en) 1993-04-05
AU679427B2 (en) 1997-07-03
CA2115049A1 (en) 1993-03-18
FI941048A0 (fi) 1994-03-04
FI941048L (fi) 1994-03-04
NO940736D0 (no) 1994-03-03
ATE173023T1 (de) 1998-11-15
ES2123008T3 (es) 1999-01-01
CN1070227A (zh) 1993-03-24
EP0602144A1 (en) 1994-06-22

Similar Documents

Publication Publication Date Title
NO940736D0 (no) DNA sekvenser som koder for gelonin polypeptid
IL86480A0 (en) Recombinant dna coding for human proapolipoprotein a-i,expression vectors containing it and cells transformed by said expression vector
AR248044A1 (es) Una secuencia de adn que codifica anticuerpos monoclonales humanizados contra interleuquinas humanas, metodo de obtencion y de seleccion de dichos anticuerpos, vector recombinante y celula huesped.
AU8635391A (en) Nucleotide sequences coding for a human protein with angiogenesis regulative properties
ES8705467A1 (es) Un procedimiento para producir la proteina apoacuorina
EP0756005A4 (en) GENE CODING FOR ADSEVERINE
DE69634918D1 (de) Polynukleotide und polypeptide aus pathogenen mycobakterien und deren verwendung als diagnostika, impfstoffe und als ziel der chemotherapie
FI961202A0 (fi) Grb3-3-geeni, sen variantteja ja niiden käyttöjä
NZ241829A (en) Oxalate oxidase, genes encoding it, vectors and transformed plants
GR3023593T3 (en) Protein structure of the plant toxin gelonin
CO4480058A1 (es) Genes codificantes y procedimiento de expresion de una nueva enzima: ftalil amidasa
IT8521507A0 (it) Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees